Related Experiment Video
Updated: May 24, 2026
A Mouse Model for Chronic Pancreatitis via Bile Duct TNBS Infusion
Published on: February 28, 2021
[Mesenchymal stromal cells transplantation in acute and chronic pancreatitis in rats]
Abstract:
Before using MSC transplantation in the clinic to conduct preclinical studies MSCs to animals with acute and chronic pancreatitis. Work out the timing and dose of MSCs. The rationale of MSCs transplantation for the regeneration of damaged pancreatic tissue. The essence of the experiments is to establish the existence of common pathogenetic mechanisms for the development of pathological processes and sanogenesis toxic damage of pancreatic tissue. The study was work out in the rat model of acute and chronic pancreatitis, to explore beneficial and adverse effects of allogeneic stem cells for regenerative-reduction processes. For cell transplantation using allogenic stromal cell fraction of bone marrow, the cell suspension was injected at a dose of 2 x 10(6) and 5 x 10(6) cells.
Insights
Mesenchymal stem cells (MSCs) show potential for treating pancreatitis. Preclinical studies in rats investigated MSC transplantation timing, dosage, and effects on pancreatic tissue regeneration.
Area of Science:
- Regenerative medicine
- Stem cell biology
- Pancreatology
Context:
- Acute and chronic pancreatitis require effective therapeutic strategies.
- Mesenchymal stem cells (MSCs) are being explored for tissue repair.
- Preclinical models are crucial for evaluating cell-based therapies.
Purpose:
- To determine the optimal timing and dosage of MSC transplantation for pancreatitis.
- To investigate the rationale behind MSC transplantation for pancreatic tissue regeneration.
- To explore the beneficial and adverse effects of allogeneic MSCs in pancreatitis models.
Summary:
- This study utilized a rat model of acute and chronic pancreatitis to assess allogeneic bone marrow-derived MSC transplantation.
- Experiments focused on establishing common pathogenetic mechanisms and evaluating MSCs' role in regenerative-reduction processes.
- Doses of 2 x 10^6 and 5 x 10^6 MSCs were administered to explore their therapeutic potential and safety.
Impact:
- Provides preclinical data to support the clinical application of MSC transplantation for pancreatitis.
- Contributes to understanding the mechanisms of MSCs in pancreatic tissue repair.
- Informs future research on optimizing stem cell therapy for pancreatic diseases.
